These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

692 related items for PubMed ID: 16122907

  • 1. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
    Lue H, Kapurniotu A, Fingerle-Rowson G, Roger T, Leng L, Thiele M, Calandra T, Bucala R, Bernhagen J.
    Cell Signal; 2006 May; 18(5):688-703. PubMed ID: 16122907
    [Abstract] [Full Text] [Related]

  • 2. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
    Lue H, Thiele M, Franz J, Dahl E, Speckgens S, Leng L, Fingerle-Rowson G, Bucala R, Lüscher B, Bernhagen J.
    Oncogene; 2007 Aug 02; 26(35):5046-59. PubMed ID: 17310986
    [Abstract] [Full Text] [Related]

  • 3. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.
    Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214
    [Abstract] [Full Text] [Related]

  • 4. Differential effect of FGF and PDGF on cell proliferation and migration in osteoblastic cells.
    Kim SJ, Kim SY, Kwon CH, Kim YK.
    Growth Factors; 2007 Apr 01; 25(2):77-86. PubMed ID: 17852407
    [Abstract] [Full Text] [Related]

  • 5. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
    Marzec M, Kasprzycka M, Liu X, Raghunath PN, Wlodarski P, Wasik MA.
    Oncogene; 2007 Feb 08; 26(6):813-21. PubMed ID: 16909118
    [Abstract] [Full Text] [Related]

  • 6. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
    Lee M.
    Biochem Biophys Res Commun; 2006 Nov 17; 350(2):450-6. PubMed ID: 17010316
    [Abstract] [Full Text] [Related]

  • 7. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation.
    Li Z, Hosoi Y, Cai K, Tanno Y, Matsumoto Y, Enomoto A, Morita A, Nakagawa K, Miyagawa K.
    Biochem Biophys Res Commun; 2006 Mar 10; 341(2):363-8. PubMed ID: 16414009
    [Abstract] [Full Text] [Related]

  • 8. Activation of calcium-dependent kinases and epidermal growth factor receptor regulate muscarinic acetylcholine receptor-mediated MAPK/ERK activation in thyroid epithelial cells.
    Montiel M, Quesada J, Jiménez E.
    Cell Signal; 2007 Oct 10; 19(10):2138-46. PubMed ID: 17643958
    [Abstract] [Full Text] [Related]

  • 9. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
    Piao C, Jin M, Kim HB, Lee SM, Amatya PN, Hyun JW, Chang IY, You HJ.
    Oncogene; 2009 May 28; 28(21):2173-84. PubMed ID: 19398949
    [Abstract] [Full Text] [Related]

  • 10. FRS2-dependent SRC activation is required for fibroblast growth factor receptor-induced phosphorylation of Sprouty and suppression of ERK activity.
    Li X, Brunton VG, Burgar HR, Wheldon LM, Heath JK.
    J Cell Sci; 2004 Dec 01; 117(Pt 25):6007-17. PubMed ID: 15564375
    [Abstract] [Full Text] [Related]

  • 11. 1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS/RAF/ERK-MAP kinase signalling pathway.
    Hughes PJ, Brown G.
    J Cell Biochem; 2006 Jun 01; 98(3):590-617. PubMed ID: 16440327
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. EGF receptor is involved in WNT3a-mediated proliferation and motility of NIH3T3 cells via ERK pathway activation.
    Kim SE, Choi KY.
    Cell Signal; 2007 Jul 01; 19(7):1554-64. PubMed ID: 17374561
    [Abstract] [Full Text] [Related]

  • 15. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R, Piperdi S, Gorlick R.
    Clin Cancer Res; 2008 Oct 15; 14(20):6396-404. PubMed ID: 18927278
    [Abstract] [Full Text] [Related]

  • 16. Src family kinase inhibitors block amphiregulin-mediated autocrine ErbB signaling in normal human keratinocytes.
    Kansra S, Stoll SW, Johnson JL, Elder JT.
    Mol Pharmacol; 2005 Apr 15; 67(4):1145-57. PubMed ID: 15615697
    [Abstract] [Full Text] [Related]

  • 17. Sustained activation of Src-family tyrosine kinases by ischemia: a potential mechanism mediating extracellular signal-regulated kinase cascades in hippocampal dentate gyrus.
    Guo J, Wu HW, Hu G, Han X, De W, Sun YJ.
    Neuroscience; 2006 Dec 15; 143(3):827-36. PubMed ID: 17000055
    [Abstract] [Full Text] [Related]

  • 18. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
    Sun CK, Man K, Ng KT, Ho JW, Lim ZX, Cheng Q, Lo CM, Poon RT, Fan ST.
    Carcinogenesis; 2008 Nov 15; 29(11):2096-105. PubMed ID: 18765415
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.